UPDATE: H.C. Wainwright Downgrades Akebia Therapeutics (AKBA) to Neutral
Tweet Send to a Friend
(Updated - March 31, 2022 7:11 AM EDT)
H.C. Wainwright analyst Ed Arce downgraded Akebia Therapeutics (NASDAQ: AKBA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
H.C. Wainwright analyst Ed Arce downgraded Akebia Therapeutics (NASDAQ: AKBA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
